Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5197927
Max Phase: Preclinical
Molecular Formula: C27H34O
Molecular Weight: 374.57
Associated Items:
ID: ALA5197927
Max Phase: Preclinical
Molecular Formula: C27H34O
Molecular Weight: 374.57
Associated Items:
Canonical SMILES: CC1(C)CCC[C@@]2(C)C1CC[C@@]1(C)Oc3ccc(-c4ccccc4)cc3C[C@@H]12
Standard InChI: InChI=1S/C27H34O/c1-25(2)14-8-15-26(3)23(25)13-16-27(4)24(26)18-21-17-20(11-12-22(21)28-27)19-9-6-5-7-10-19/h5-7,9-12,17,23-24H,8,13-16,18H2,1-4H3/t23?,24-,26+,27-/m1/s1
Standard InChI Key: GLYNHUHUYQIGDC-UFKXEZKMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 374.57 | Molecular Weight (Monoisotopic): 374.2610 | AlogP: 7.29 | #Rotatable Bonds: 1 |
Polar Surface Area: 9.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 7.40 | CX LogD: 7.40 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.51 | Np Likeness Score: 1.77 |
1. Wang X, Hu N, Kong W, Song B, Li S.. (2022) Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads., 227 [PMID:34653771] [10.1016/j.ejmech.2021.113912] |
Source(1):